We are live on ! Find out more
SC

Schulhoff & Co Portfolio holdings

AUM $243M
1-Year Est. Return 17.47%
This Fund
S&P 500
This Quarter Est. Return
+3.51%
1 Year Est. Return
+17.47%
3 Year Est. Return
+42.69%
5 Year Est. Return
+58.83%
10 Year Est. Return
+178.36%
AUM
$238M
AUM Growth
+$3.32M
Cap. Flow
-$2.31M
Cap. Flow %
-0.97%
Top 10 Hldgs %
40.65%
Holding
138
New
3
Increased
34
Reduced
36
Closed
6

Top Buys

Rank Stock Value
1
CTMX icon
CytomX Therapeutics
CTMX
+$1.42M
2
PSLV icon
Sprott Physical Silver Trust
PSLV
+$566K
3
Q
Qnity Electronics Inc
Q
+$357K
4
CB icon
Chubb
CB
+$189K
5
WU icon
Western Union
WU
+$148K

Top Sells

Rank Stock Value
1
AVDL
Avadel Pharmaceuticals
AVDL
+$2.1M
2
PYXS icon
Pyxis Oncology
PYXS
+$611K
3
DD icon
DuPont de Nemours
DD
+$452K
4
SLV icon
iShares Silver Trust
SLV
+$441K
5
CTAS icon
Cintas
CTAS
+$290K

Sector Composition

Rank Sector Weight
1 Financials 21.72%
2 Consumer Staples 17.43%
3 Industrials 12.82%
4 Healthcare 12.68%
5 Technology 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NOC icon
26
Northrop Grumman
NOC
$73.7B
$2.18M 0.92%
3,827
-2
-0.1% -$1.16K
SMG icon
27
ScottsMiracle-Gro
SMG
$4.27B
$2.17M 0.91%
37,173
-562
-1% -$31.5K
WM icon
28
Waste Management
WM
$97.3B
$2.12M 0.89%
9,663
+4
+0% +$853
GE icon
29
GE Aerospace
GE
$361B
$2.06M 0.87%
6,694
+3
+0% +$903
BAC icon
30
Bank of America
BAC
$432B
$1.96M 0.82%
35,554
+24
+0.1% +$1.27K
MDLZ icon
31
Mondelez International
MDLZ
$78.8B
$1.95M 0.82%
36,250
+1,030
+3% +$59.3K
T icon
32
AT&T
T
$153B
$1.9M 0.8%
76,327
-2,205
-3% -$55.8K
UPS icon
33
United Parcel Service
UPS
$99.6B
$1.87M 0.79%
18,845
-484
-3% -$45.3K
VZ icon
34
Verizon
VZ
$183B
$1.86M 0.78%
45,575
+13
+0% +$527
MCD icon
35
McDonald's
MCD
$194B
$1.83M 0.77%
5,988
– –
HON icon
36
Honeywell
HON
$71.7B
$1.71M 0.72%
8,770
-531
-6% -$104K
CTMX icon
37
CytomX Therapeutics
CTMX
$798M
$1.6M 0.67%
+374,850
New +$1.42M
AXP icon
38
American Express
AXP
$247B
$1.59M 0.67%
4,300
– –
WSBC icon
39
WesBanco
WSBC
$3.96B
$1.41M 0.59%
42,275
+740
+2% +$23.9K
BNY
40
Bank of New York Mellon
BNY
$110B
$1.37M 0.58%
11,833
+2
+0% +$221
MKC icon
41
McCormick & Company Non-Voting
MKC
$14.2B
$1.36M 0.57%
20,038
+21
+0.1% +$1.4K
MRK icon
42
Merck
MRK
$315B
$1.29M 0.54%
12,263
– –
LOW icon
43
Lowe's Companies
LOW
$121B
$1.24M 0.52%
5,162
– –
KMB icon
44
Kimberly-Clark
KMB
$36.2B
$1.24M 0.52%
12,318
-668
-5% -$73.1K
MEDP icon
45
Medpace
MEDP
$15.4B
$1.24M 0.52%
2,202
+25
+1% +$14.2K
DUK icon
46
Duke Energy
DUK
$98.3B
$1.22M 0.51%
10,434
– –
PFE icon
47
Pfizer
PFE
$143B
$1.21M 0.51%
48,502
-970
-2% -$24.5K
MDT icon
48
Medtronic
MDT
$107B
$1.16M 0.49%
12,121
– –
BMY icon
49
Bristol-Myers Squibb
BMY
$124B
$1.13M 0.48%
20,914
-1,500
-7% -$72.2K
PSLV icon
50
Sprott Physical Silver Trust
PSLV
$11.4B
$1.09M 0.46%
45,900
+30,900
+206% +$566K
1
2
3 4 5

Similar funds

HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
YP
YANKCOM Partnership Yankton, South Dakota $243M AUM 21.59% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
QHA
Quarry Hill Advisors St Paul, Minnesota $243M AUM 24.02% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
BB
Burford Brothers Dallas, Texas $244M AUM 24.94% 1-Year Est. Return

Schulhoff & Co's Q4 2025 Portfolio in Review

As of Q4 2025, Schulhoff & Co held 138 positions worth $238M, up 1.4% from $234M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Schulhoff & Co's Q4 2025 filing shows 3 new, 34 increased, 36 reduced and 6 closed positions. Its largest new stake was CytomX Therapeutics: 374,850 shares worth $1.6M. The largest sale was Avadel Pharmaceuticals, an estimated $2.1M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Consumer Staples and Industrials.

  • Schulhoff & Co's largest Q4 2025 buy was CytomX Therapeutics: 374,850 shares worth $1.6M.
  • Schulhoff & Co added most to Sprott Physical Silver Trust in Q4 2025, an estimated $566K increase.
  • Schulhoff & Co's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $452K.
  • Schulhoff & Co fully exited Avadel Pharmaceuticals in Q4 2025, selling an estimated $2.1M.
  • Schulhoff & Co's ten largest holdings make up 41% of its $238M portfolio in Q4 2025.
  • Schulhoff & Co opened 3 new positions and closed 6 in Q4 2025.
  • Schulhoff & Co's portfolio value rose 1.4% quarter-over-quarter to $238M.

Based on Schulhoff & Co's 13F filing for Q4 2025, filed 11 Feb 2026.